FDA Investigator Marian E Ramirez

Marian E Ramirez has conducted inspections on 61 sites in 9 countries as of 27 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
61
Last Inspection Date:
27 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Brazil, India, Puerto Rico, Colombia, Canada, Spain, China, United States of America, France
FDA Investigators that have inspected at least one site in common with Marian E Ramirez:
Adalberto Cajigas, Adaliz Santaliz Cruz, Agnes M Santori, Alan A Rivera, Alan P Kurtzberg, Alonso, An T Vu, Ana M Rivera, Anastasia M Shields, Andrea George, PhD, Angelica M Hernandez, Ann L Demarco, Ariel Cruz Figueroa, Arlene M Badillo, Ashley N Queen, PhD, Aurora Miha Trifanov, Azza Talaat, Bill Tacket, Jr, Brenda Rivera, Brian J Ryan, Brian L Belz, Calvin B Koerner, Candace S Tucker, Carlos A Medina, Carpios, Carrie A Hughes, Cassandra L Abellard, CDR Ileana Barreto Pettit, Charanjeet Jassal, Charisse K Green, Charles M Edwards, Chelsea N Sealey, Cheryl A Clausen, Christopher Downey, PhD, Colleen Thomas, PhD, Damaris Y Hernandez, Daniel J Roberts, Daniel L Obrzut, Daryl A Dewoskin, David J Hafner, Dayna I Martinez, Dennis Cantellops Paite, Dewayne E Whitlock, Djamila Harouaka, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Dorothy P Kramer, Dov H Pluznik, PhD, Dr. Carmelo Rosa, Dr. Zhihao Qiu (Peter), PhD, Edward D Mcdonald, Edwin Martinez, Eileen A Liu, Eliezar Ramos, Eric M Mueller, PharmD, Erika V Butler, Eva I Merced Medina, Felix Maldonado, Frances L Dejesus, Francis A Guidry, Garcial, German Rivera, Gwyn G Dickinson, Hala L Selby, Iraida Ortiz, Ivis L Negron, Ivonne A Vicente, Jaime E Pares, Jason F Chancey, Javier O Vega, Jennifer A Quinones, Jennifer Lalama, Jerri Baker, Joan M Cantellops Figueroa, Jogy George, Jorge E Martinez, Jorge L Guadalupe, Jorge L Lajara, Jose A Lopez, Jose Acruz Gonzalez, José E Meléndez, Jose F Pedro, Jose M Cayuela, Jose Martinez, Jr, Jose R Lopez, Jose Rflores Veguilla, Jose Velez, Katherine Szestypalow, Kayla V Sprague, Krishna Ghosh, PhD, Kristy A Zielny, Kristy E Zuroski, Laiza V Garcia, Lareese K Thomas, Laura E Garcia, Laurimer Kuilan Torres, Libia M Lugo, Lindsey M Schwierjohann, Lisa A Warner, Lisa M Lopez, Lizaida E Rodriguez, Lloyd D Payne, Loreily Figueroa Agrinsoni, Lourdes Andujar, LT Daveta L Bailey, LT Luis O Rodriguez, LT Rafael Gonzalez, Mabany Lizardi, Margarita Santiago, Maria Gutierrez Lugo, PhD, Marianela Aponte Cruz, Maricelys Mercado, Maridalia Torres Irizarry, Marie A Fadden, Marilyn Santiago, Marisol Faberlle, Marlene Rodriguez Colon, Matthew C Watson, Maxwell Van Tassell, PhD, Melanie G Warzala, Melanie W Pishnery, Michael A Charles, Michael L Casner, Michael Levy, Michael P Sheehan, Michael R Goga, Michael R Klapal, Michael Shanks, MS, Michele L Glendenning, Michelle Yclark Stuart, Miguel A Martinez Perez, Miguel Gmanzano Maldonado, Milva E Melendez Perales, Monica E Caphart, Myriam M Sosa, Nancy Rosado, Nicholas Obiri, PhD, Nicole E Knowlton, Nikolay Spiridonov, Noreen Muñiz, Nydia E Colon, Omotunde O Osunsanmi, Pablo Feliciano, Parul M Patel, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Paul Z Balcer, Paula A Trost, Qin Xu, Rafael E Arroyo, Rafael Nevarez Nieves, Ramesh Potla, PhD, Ramon A Hernandez, Rapti D Madurawe, Raquel Gonzalez Rivera, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Parrilla, Rebecca Rodriguez, Riley C Myers, PhD, Robert Darius, Robert J Martin, Rosa J Motta, Ruben C Ayala, PharmD, S Lori Brown, PhD MPH, Samina S Khan, Sandra Carpio, Sangeeta M Khurana, PhD, Sarah E Mcmullen, Satheesh Thomas, Sonia M Monges, Sony Mathews, Stephanie D Crockett, Steven B Barber, Steven C Madzo, Steven D Kehoe, Steven Fong, MS, PhD, Steven M Weinman, Steven P Donald, Susanne M Richardson, MS RAC, Tajah L Blackburn, Teresa I Navas, Thomas J Arista, Timothy Wadkin, PhD, Tomika L Bivens, Truong Xuan Nguyen (Andy), Vilmary Negron Rodriguez, Walden H Lee, Wanda J Torres, Wendy G Tan, PhD, William J Leonard, Yifan Wang, Ying Zhang, Youmin Wang, Zachary L Stamm, Zhong Li, PhD, Zhongren Wu

Marian E Ramirez's Documents

Publish Date Document Type Title
July, 2021 EIR Caribe Holdings (Cayman) Co.ltd. DBA PuraCap Caribe - EIR, 2021-07-02
February, 2022 EIR Viatris Pharmaceuticals LLC - EIR, 2022-02-17
February, 2020 FDA 483 MSD International GmbH (Puerto Rico Branch) LLC - Form 483, 2020-02-26
March, 2018 FDA 483 Auro PR Inc. - Form 483, 2018-03-15
December, 2023 FDA 483 Gasco Industrial Corp. - Form 483, 2023-12-08
May, 2022 FDA 483 Omega & Delta Co. Inc. - Form 483, 2022-05-06
February, 2022 FDA 483 Response Viatris Pharmaceuticals LLC - Form 483R, 2022-03-11
February, 2022 FDA 483 Viatris Pharmaceuticals LLC - Form 483, 2022-02-17
March, 2020 FDA 483 Caribe Holdings (Cayman) Co.ltd. DBA PuraCap Caribe - Form 483, 2020-03-10
February, 2023 FDA 483 Lilly del Caribe, Inc. - Form 483, 2023-02-17
February, 2020 EIR MSD International GmbH (Puerto Rico Branch) LLC - EIR, 2020-02-26
May, 2023 FDA 483 Auro PR Inc. - Form 483, 2023-05-31
September, 2022 FDA 483 Taro Pharmaceuticals Inc. - Form 483, 2022-09-16
April, 2022 FDA 483 Neolpharma, Inc. - Form 483, 2022-04-01
August, 2019 EIR Formulated Solutions, LLC - EIR, 2019-08-29
March, 2019 FDA 483 Boehringer Ingelheim Animal Health Puerto Rico LLC - Form 483, 2019-03-29
January, 2018 EIR Viatris Pharmaceuticals LLC - EIR, 2018-01-26
July, 2022 FDA 483 Patheon Puerto Rico, Inc. - Form 483, 2022-07-12
November, 2021 FDA 483 Janssen-Cilag Manufacturing, LLC - Form 483, 2021-11-23
March, 2018 EIR Auro PR Inc. - EIR, 2018-03-15
October, 2016 FDA 483 Auro PR Inc. - Form 483, 2016-10-24
August, 2022 FDA 483 Frenda Corporation - Form 483, 2022-08-01
August, 2018 EIR Teva Puerto Rico LLC - EIR, 2018-08-10
August, 2016 FDA 483 Destileria Serralles, Inc. - Form 483, 2016-08-09
October, 2023 FDA 483 Omega & Delta Co. Inc. - Form 483, 2023-10-23
November, 2021 FDA 483 Response Janssen-Cilag Manufacturing, LLC - Form 483R, 2021-12-15
July, 2021 FDA 483 Caribe Holdings (Cayman) Co.ltd. DBA PuraCap Caribe - Form 483, 2021-07-02
January, 2023 FDA 483 Galephar Pharmaceutical Research Inc. - Form 483, 2023-01-20
December, 2019 FDA 483 Laboratorios Rety de Colombia SAS - Form 483, 2019-12-06
March, 2024 FDA 483 Max Chemical, Inc. - Form 483, 2024-03-15
January, 2018 FDA 483 Viatris Pharmaceuticals LLC - Form 483, 2018-01-26
July, 2021 FDA 483 Response Caribe Holdings (Cayman) Co.ltd. DBA PuraCap Caribe - Form 483R, 2021-07-26
August, 2023 FDA 483 INOVAT Industria Farmaceutica LTDA. - Form 483, 2023-08-09
October, 2016 FDA 483 Warner Chilcott Company, LLC - Form 483, 2016-10-03
February, 2024 FDA 483 Lilly del Caribe, Inc. - Form 483, 2024-02-16
September, 2023 FDA 483 McNeil Healthcare LLC. - Form 483, 2023-09-20
July, 2023 FDA 483 Response Amgen Manufacturing Limited LLC - Form 483R, 2023-07-19
July, 2023 FDA 483 Amgen Manufacturing Limited LLC - Form 483, 2023-07-05
January, 2024 FDA 483 Little Moon Essentials - Form 483, 2024-01-18
November, 2021 EIR Janssen-Cilag Manufacturing, LLC - EIR, 2021-11-23
July, 2019 FDA 483 Lilly del Caribe, Inc. - Form 483, 2019-07-12
March, 2019 FDA 483 Caribe Holdings (Cayman) Co.ltd. DBA PuraCap Caribe - Form 483, 2019-03-06
November, 2019 FDA 483 Galephar Pharmaceutical Research Inc. - Form 483, 2019-11-01
May, 2024 FDA 483 Guang'an Kingday Pharma & Chem Co., Ltd - Form 483, 2024-05-24

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more